Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
481
datasets available to search
ShareScore release 0.9.0
Dataset results
481 results for “Kidney cancer”
Processed data for MethylBoostER: an XGBoost model to classify kidney cancer subtypes
<p>This is a repository containing processed data for MethylBoostER, an XGBoost model that classifies kidney cancer subtypes. The open-source code can be found here: https://github.com/ss-lab-cancerunit/MethylBoostER.</p>
Imaging Studies of Kidney Cancer Using 18F-VM4-037
ClinicalTrials.gov study NCT01712685. IPD Sharing: NO. Countries: 1. Publications: 4.
Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed
ClinicalTrials.gov study NCT02761057. IPD Sharing: Not stated. Countries: 2. Publications: 3.
Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer
ClinicalTrials.gov study NCT00425386. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov study NCT01164228. IPD Sharing: YES. Countries: 1. Publications: 1.
Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau
ClinicalTrials.gov study NCT03907657. IPD Sharing: NO. Countries: 1. Publications: 1.
Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer
ClinicalTrials.gov study NCT01064310. IPD Sharing: Not stated. Countries: 5. Publications: 4.
A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.
ClinicalTrials.gov study NCT05363072. IPD Sharing: NO. Countries: 1. Publications: 1.
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer
ClinicalTrials.gov study NCT01599832. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT00459979. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Vandetanib to Treat Advanced Kidney Cancer
ClinicalTrials.gov study NCT01372813. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov study NCT00126594. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer
ClinicalTrials.gov study NCT00328861. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney
ClinicalTrials.gov study NCT03138512. IPD Sharing: NO. Countries: 25. Publications: 3.
Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers
ClinicalTrials.gov study NCT03816332. IPD Sharing: YES. Countries: 1. Publications: 3.
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
ClinicalTrials.gov study NCT01575548. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer
ClinicalTrials.gov study NCT01158521. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer
ClinicalTrials.gov study NCT02504892. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer
ClinicalTrials.gov study NCT00719264. IPD Sharing: Not stated. Countries: 21. Publications: 2.
Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer
ClinicalTrials.gov study NCT04337970. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.